DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Urokinase

Urokinase

  • Urokinase, a Promising Candidate for Fibrinolytic Therapy for Intracerebral Hemorrhage

    Urokinase, a Promising Candidate for Fibrinolytic Therapy for Intracerebral Hemorrhage

  • 2-Diss Preface1

    2-Diss Preface1

  • Replacing the First Epidermal Growth Factor-Like Domain of Factor IX with That of Factor VII Enhances Activity in Vitro and in Canine Hemophilia B

    Replacing the First Epidermal Growth Factor-Like Domain of Factor IX with That of Factor VII Enhances Activity in Vitro and in Canine Hemophilia B

  • Therapeutic Fibrinolysis How Efficacy and Safety Can Be Improved

    Therapeutic Fibrinolysis How Efficacy and Safety Can Be Improved

  • The Molecular Basis of Blood Coagulation Review

    The Molecular Basis of Blood Coagulation Review

  • Mechanism of Ancrod Anticoagulation: a Direct Proteolytic Effect on Fibrin

    Mechanism of Ancrod Anticoagulation: a Direct Proteolytic Effect on Fibrin

  • (12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan Et Al

    (12) Patent Application Publication (10) Pub. No.: US 2004/0081648A1 Afeyan Et Al

  • 12) United States Patent (10

    12) United States Patent (10

  • Enhancement of the Expression of Urokinase-Type Plasminogen Activator from PC-3 Human Prostate Cancer Cells by Thrombin'

    Enhancement of the Expression of Urokinase-Type Plasminogen Activator from PC-3 Human Prostate Cancer Cells by Thrombin'

  • Thrombin Increases Expression of Urokinase Receptor by Activation of the Thrombin Receptor

    Thrombin Increases Expression of Urokinase Receptor by Activation of the Thrombin Receptor

  • Protein C Inhibitor Is Expressed in Keratinocytes of Human Skin

    Protein C Inhibitor Is Expressed in Keratinocytes of Human Skin

  • Urokinase for Injection)

    Urokinase for Injection)

  • Enhanced Expression of Urokinase Receptor Induced Through the Tissue Factor- Factor Vila Pathway in Human Pancreatic Cancer1

    Enhanced Expression of Urokinase Receptor Induced Through the Tissue Factor- Factor Vila Pathway in Human Pancreatic Cancer1

  • PCSK9 at 1.9 Å Reveals Structural Homology with Resistin Within the C-Terminal Domain

    PCSK9 at 1.9 Å Reveals Structural Homology with Resistin Within the C-Terminal Domain

  • Nattokinase, Streptokinase and Urokinase) from Bacterial Sources

    Nattokinase, Streptokinase and Urokinase) from Bacterial Sources

  • Lachesis Muta (Viperidae) Cdnas Reveal Diverging Pit Viper Molecules and Scaffolds Typical of Cobra (Elapidae) Venoms: Implicati

    Lachesis Muta (Viperidae) Cdnas Reveal Diverging Pit Viper Molecules and Scaffolds Typical of Cobra (Elapidae) Venoms: Implicati

  • Identification of High Abundance Expressed Sequence Tags (Ests) from the Venom Glands of Bothrops Insularis Snake

    Identification of High Abundance Expressed Sequence Tags (Ests) from the Venom Glands of Bothrops Insularis Snake

  • Heparin As a Tunneled Catheter Lock Solution in Hemodialysis Patients: a Prospective, Randomized, Controlled Study

    Heparin As a Tunneled Catheter Lock Solution in Hemodialysis Patients: a Prospective, Randomized, Controlled Study

Top View
  • Tissue Plasminogen Activator (Tpa) Inhibits Plasmin Degradation of Fibrin
  • Heparin Binding to Protein C Inhibitor
  • The Effect of Salicylates on Aqueous Fibrinolysin
  • Regulation of Hepatocyte Growth Factor-Mediated Urokinase Plasminogen Activator Secretion by MEK/ERK Activation in Human Stomach Cancer Cell Lines
  • Overview of the Therapeutic Potential of Aptamers Targeting Coagulation Factors
  • FACTOR X FACTORS XI and XII 1 ,O
  • Example of a Protocol for Intra-Arterial Thrombolysis
  • ANTICOAGULANT, THROMBOLYTIC, and ANTI-PLATELET DRUGS
  • The Proprotein Convertase Furin Is a Key Regulator of Paediatric Sarcoma Malignancy
  • Urokinase - a Strong Plasminogen Activator
  • Gingival Crevicular Fluid Zinc- and Aspartyl-Binding Protease Profile of Individuals with Moderate/Severe Atopic Dermatitis
  • Factor IX: Clinical and Experimental
  • COUMADIN® TABLETS (Warfarin Sodium Tablets, USP) Crystalline COUMADIN® for INJECTION (Warfarin Sodium for Injection, USP) Anticoagulant
  • MINI REVIEW CD87 (Urokinase-Type Plasminogen Activator Receptor)


© 2024 Docslib.org    Feedback